Drug intelligence / Profile preview

metampicillin

Development stage
Unknown
Lead developer
Ferrero
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Metampicillin is a β-lactam antibiotic of the penicillin class, prepared by reacting ampicillin with formaldehyde. It acts as a prodrug, rapidly hydrolyzed in acidic environments such as the stomach to release ampicillin. Metampicillin exerts its antibacterial effect by inhibiting bacterial cell wall synthesis through binding and inactivation of penicillin-binding proteins (PBPs), which are essential for cross-linking peptidoglycan chains and maintaining cell wall integrity. This leads to weakening of the bacterial cell wall and eventual lysis. Metampicillin has a similar antibacterial spectrum to ampicillin but is reported to be absorbed more efficiently when administered orally or parenterally, resulting in higher blood and biliary concentrations compared to ampicillin alone. It is particularly effective for treating biliary tract infections due to its high accumulation in bile[1][2][3][4][5].

02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on metampicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metampicillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call